BCRX
Price
$8.61
Change
-$0.09 (-1.03%)
Updated
Jul 18 closing price
Capitalization
1.8B
11 days until earnings call
ETNB
Price
$10.49
Change
-$0.16 (-1.50%)
Updated
Jul 18 closing price
Capitalization
1.53B
18 days until earnings call
Interact to see
Advertisement

BCRX vs ETNB

Header iconBCRX vs ETNB Comparison
Open Charts BCRX vs ETNBBanner chart's image
BioCryst Pharmaceuticals
Price$8.61
Change-$0.09 (-1.03%)
Volume$3.11M
Capitalization1.8B
89bio
Price$10.49
Change-$0.16 (-1.50%)
Volume$1.31M
Capitalization1.53B
BCRX vs ETNB Comparison Chart in %
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. ETNB commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and ETNB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (BCRX: $8.61 vs. ETNB: $10.49)
Brand notoriety: BCRX: Notable vs. ETNB: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 83% vs. ETNB: 67%
Market capitalization -- BCRX: $1.8B vs. ETNB: $1.53B
BCRX [@Biotechnology] is valued at $1.8B. ETNB’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileETNB’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • ETNB’s FA Score: 1 green, 4 red.
According to our system of comparison, ETNB is a better buy in the long-term than BCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 4 TA indicator(s) are bullish while ETNB’s TA Score has 4 bullish TA indicator(s).

  • BCRX’s TA Score: 4 bullish, 5 bearish.
  • ETNB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both BCRX and ETNB are a bad buy in the short-term.

Price Growth

BCRX (@Biotechnology) experienced а -1.71% price change this week, while ETNB (@Biotechnology) price change was -4.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

ETNB is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($1.8B) has a higher market cap than ETNB($1.53B). ETNB YTD gains are higher at: 34.143 vs. BCRX (14.495). BCRX has higher annual earnings (EBITDA): 47.6M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. BCRX (295M). ETNB has less debt than BCRX: ETNB (37.6M) vs BCRX (795M). BCRX has higher revenues than ETNB: BCRX (503M) vs ETNB (0).
BCRXETNBBCRX / ETNB
Capitalization1.8B1.53B118%
EBITDA47.6M-380.21M-13%
Gain YTD14.49534.14342%
P/E RatioN/AN/A-
Revenue503M0-
Total Cash295M639M46%
Total Debt795M37.6M2,114%
FUNDAMENTALS RATINGS
BCRX: Fundamental Ratings
BCRX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCRXETNB
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
88%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCBX45.970.15
+0.33%
MFS Technology B
NOIEX18.020.02
+0.11%
Northern Income Equity
HGIIX56.05-0.03
-0.05%
Hartford Core Equity I
LKSMX11.69-0.04
-0.34%
LKCM Small-Mid Cap Equity Institutional
HGHYX40.08-0.37
-0.91%
Hartford Healthcare Y

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with CRNX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-1.03%
CRNX - BCRX
41%
Loosely correlated
-5.78%
ETNB - BCRX
39%
Loosely correlated
-1.50%
BEAM - BCRX
39%
Loosely correlated
+1.47%
DNLI - BCRX
39%
Loosely correlated
-3.65%
MLTX - BCRX
38%
Loosely correlated
N/A
More

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
-1.50%
AKRO - ETNB
60%
Loosely correlated
-4.14%
IDYA - ETNB
55%
Loosely correlated
-2.26%
DNLI - ETNB
52%
Loosely correlated
-3.65%
SNDX - ETNB
51%
Loosely correlated
-2.17%
BEAM - ETNB
51%
Loosely correlated
+1.47%
More